777 abstracts found.



Results filter

Evaluation of multiple drug resistance in acute leukemia by real time PCR (RT-PCR)

Year:

Session type:

Eman Mosad1, Rania M Bakry1, Eman Hassan1
1South Egypt Cancer Institute, Assiut, Egypt

Glycoproteomics identifies cadherin-5 as a novel serum biomarker of metastatic breast cancer

Year:

Session type:

Simon Fry1, John Sinclair2, John Timms2, Anthony Leathem2, Miriam Dwek1
1University of Westminster, London, UK, 2University College London, London, UK

DNA repair proteins XPF and MUS81 are predictive biomarkers for oxaliplatin-fluorouracil chemotherapy in patients with oesophageal cancer

Year:

Session type:

Thomas MacGregor1,2, Richard Gillies2, Natasha Sahgal3, Rebecca Carter1, Runjan Chetty4, Lai-Mun Wang4, Nicholas Maynard2, Peter McHugh5, Mark Middleton1, Ricky Sharma1
1Department of Oncology, Oxford NIHR Biomedical Research Centre, Churchill Hospital, Oxford, UK, 2Department of Upper GI Surgery, Churchill Hospital, OUH NHS Trust, Oxford, UK, 3Wellcome Trust Centre for Human Genetics, Oxford, UK, 4Oxford NIHR Biomedical Research Centre/Department of Cellular Pathology OUH NHS Trust, Oxford, UK, 5Department of Oncology, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK

International Cancer Benchmarking Partnership (ICBP) Module 4: Root Causes of Diagnosis and Treatment Delay in Four Cancer Sites: Lessons Learnt from the Northern Ireland Pilot Study

Year:

Session type:

Jackie Boylan1, Anna Gavin1, Conan Donnelly1, Module 4 Working Group2
1Queen's University Belfast, Belfast, UK, 2ICBP Module 4 Working Group, Canada, Australia, UK, Norway, Denmark, Sweden, UK

Neoadjuvant chemotherapy and prognostic subgroups defined by survival benefit in patients with locoregionally advanced nasopharyngeal carcinoma

Year:

Session type:

Messaoud Ayad1, Kahina Rabahi1, Kada Boualga1
1Centre Anti-Cancer, Blida, Algeria

Clinical utility of serum epigenetics in cutaneous melanoma

Year:

Session type:

Hexiao Wang1, Lynda Weir1, Bhavya Rao1, Rubeta Matin2, Angela McHugh1, Colin Fleming3, Alan Evans4, Irene Leigh1, Gareth Inman1, Catherine Harwood2, Tim Crook1, Charlotte Proby1
1Division of Cancer Research, Ninewells Hospital & Medical School, University of Dundee, Dundee, UK, 2Centre for Cutaneous Research, Barts and the London Queen Mary University of London, London, UK, 3Department of Dermatology, Ninewells Hospital, Dundee, UK, 4Department of Pathology, Ninewells Hospital, Dundee, UK

Current attitudes of head and neck oncologists in the United Kingdom to induction chemotherapy for locally advanced head and neck cancer: A survey of centres participating in a national randomised controlled trial

Year:

Session type:

Dorothy M Gujral1, Deborah Piercy2, James P Morden2, Marie Emson2, Emma Hall2, Aisha B Miah1, Shree A Bhide1, Katie L Newbold1, Kevin J Harrington1,3, Chris M Nutting1,3
1Head and Neck Unit, Royal Marsden Hospital, London, UK, 2Clinical Trials and Statistics Unit, Institute of Cancer Research, London, UK, 3Division of Radiotherapy and Imaging, Institute of Cancer Research, London, UK

Page 78 of 78« First...25...78